The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.
Two injections of inclisiran a year and you can forget about high cholesterol. Novartis doesn’t lie.
Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.